Heather Rozjabek
Biographic Data
| ID | 7690111 |
|---|---|
| NAME | Heather Rozjabek |
| GIVEN NAMES | Heather |
| FAMILY NAME | Rozjabek |
| SIGNATURE | ROZJABEK H |
| AFFILIATIONS | National Cancer Institute |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: A pooled analysis of two randomized phase 3 trials (Aspire I and Aspire II)
ClinicalTrials.gov Identifier: ASPIRE I, NCT03039192 (Registration date: February 1, 2017); ASPIRE II, NCT03097133 (Registration date: March 31, 2017)
Annual Patient Time Costs Associated With Medical Care Among Cancer Survivors in the United States
BACKGROUND: Although patient time costs are recommended for inclusion in cost-effectiveness analyses, these data are not routinely collected. We used nationally representative data and a medical service-based approach to estimate the annual patient time costs among cancer survivors. METHODS: We identified adult 6699 cancer survivors and 86,412 individuals without a cancer history ages 18 years or more from 2008-2011 Medical Expenditure Panel Surv…
Culturally Sensitive Approaches to Recruitment and Retention of Hispanics in the National Lung Screening Trial
No prominent works on this page.
Culturally Sensitive Approaches to Recruitment and Retention of Hispanics in the National Lung Screening Trial
Annual Patient Time Costs Associated With Medical Care Among Cancer Survivors in the United States
BACKGROUND: Although patient time costs are recommended for inclusion in cost-effectiveness analyses, these data are not routinely collected. We used nationally representative data and a medical service-based approach to estimate the annual patient time costs among cancer survivors. METHODS: We identified adult 6699 cancer survivors and 86,412 individuals without a cancer history ages 18 years or more from 2008-2011 Medical Expenditure Panel Surv…
Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: A pooled analysis of two randomized phase 3 trials (Aspire I and Aspire II)
ClinicalTrials.gov Identifier: ASPIRE I, NCT03039192 (Registration date: February 1, 2017); ASPIRE II, NCT03097133 (Registration date: March 31, 2017)
Medicine (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Environmental health (2 works) · Family medicine (2 works) · Internal Medicine (2 works) · Psychology (2 works) · Public health (2 works) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 works) · Beck Depression Inventory (1 works)